These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 16365041)
1. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. Wang B; Sun J; Kitamoto S; Yang M; Grubb A; Chapman HA; Kalluri R; Shi GP J Biol Chem; 2006 Mar; 281(9):6020-9. PubMed ID: 16365041 [TBL] [Abstract][Full Text] [Related]
2. Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice. Yu W; Liu J; Shi MA; Wang J; Xiang M; Kitamoto S; Wang B; Sukhova GK; Murphy GF; Orasanu G; Grubb A; Shi GP PLoS One; 2010 Nov; 5(11):e13973. PubMed ID: 21085595 [TBL] [Abstract][Full Text] [Related]
3. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Gocheva V; Zeng W; Ke D; Klimstra D; Reinheckel T; Peters C; Hanahan D; Joyce JA Genes Dev; 2006 Mar; 20(5):543-56. PubMed ID: 16481467 [TBL] [Abstract][Full Text] [Related]
4. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. Veillard F; Saidi A; Burden RE; Scott CJ; Gillet L; Lecaille F; Lalmanach G J Biol Chem; 2011 Oct; 286(43):37158-67. PubMed ID: 21896479 [TBL] [Abstract][Full Text] [Related]
5. Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner. Xie L; Duncan MB; Pahler J; Sugimoto H; Martino M; Lively J; Mundel T; Soubasakos M; Rubin K; Takeda T; Inoue M; Lawler J; Hynes RO; Hanahan D; Kalluri R Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9939-44. PubMed ID: 21622854 [TBL] [Abstract][Full Text] [Related]
6. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Aoki T; Kataoka H; Ishibashi R; Nozaki K; Hashimoto N Stroke; 2008 Sep; 39(9):2603-10. PubMed ID: 18635848 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Joyce JA; Baruch A; Chehade K; Meyer-Morse N; Giraudo E; Tsai FY; Greenbaum DC; Hager JH; Bogyo M; Hanahan D Cancer Cell; 2004 May; 5(5):443-53. PubMed ID: 15144952 [TBL] [Abstract][Full Text] [Related]
8. rd1 Mouse retina shows an imbalance in the activity of cysteine protease cathepsins and their endogenous inhibitor cystatin C. Ahuja S; Ahuja-Jensen P; Johnson LE; Caffé AR; Abrahamson M; Ekström PA; van Veen T Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1089-96. PubMed ID: 18326735 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin. Folkman J Sci STKE; 2006 Sep; 2006(354):pe35. PubMed ID: 17003465 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves. Helske S; Syväranta S; Lindstedt KA; Lappalainen J; Oörni K; Mäyränpää MI; Lommi J; Turto H; Werkkala K; Kupari M; Kovanen PT Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1791-8. PubMed ID: 16728655 [TBL] [Abstract][Full Text] [Related]
11. VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Chang SH; Kanasaki K; Gocheva V; Blum G; Harper J; Moses MA; Shih SC; Nagy JA; Joyce J; Bogyo M; Kalluri R; Dvorak HF Cancer Res; 2009 May; 69(10):4537-44. PubMed ID: 19435903 [TBL] [Abstract][Full Text] [Related]
12. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Hamano Y; Kalluri R Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458 [TBL] [Abstract][Full Text] [Related]
13. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Gocheva V; Chen X; Peters C; Reinheckel T; Joyce JA Biol Chem; 2010 Aug; 391(8):937-45. PubMed ID: 20731543 [TBL] [Abstract][Full Text] [Related]
14. Tofacitinib Regulates Endostatin via Effects on CD147 and Cathepsin S. Zisman D; Sabtan H; Rahat MM; Simanovich E; Haddad A; Gazitt T; Feld J; Slobodin G; Kibari A; Elias M; Rahat MA Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000375 [TBL] [Abstract][Full Text] [Related]
15. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Azar DT Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348 [TBL] [Abstract][Full Text] [Related]
16. Secreted cathepsin L generates endostatin from collagen XVIII. Felbor U; Dreier L; Bryant RA; Ploegh HL; Olsen BR; Mothes W EMBO J; 2000 Mar; 19(6):1187-94. PubMed ID: 10716919 [TBL] [Abstract][Full Text] [Related]
17. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice. Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908 [TBL] [Abstract][Full Text] [Related]
18. Generation and degradation of human endostatin proteins by various proteinases. Ferreras M; Felbor U; Lenhard T; Olsen BR; Delaissé J FEBS Lett; 2000 Dec; 486(3):247-51. PubMed ID: 11119712 [TBL] [Abstract][Full Text] [Related]
19. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells. Colella R; Casey SF Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846 [TBL] [Abstract][Full Text] [Related]
20. Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. Small DM; Burden RE; Jaworski J; Hegarty SM; Spence S; Burrows JF; McFarlane C; Kissenpfennig A; McCarthy HO; Johnston JA; Walker B; Scott CJ Int J Cancer; 2013 Nov; 133(9):2102-12. PubMed ID: 23629809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]